MDSpire - MDSpire Home

MDSpire - MDSpire Home

Home About

Advertisement

What is MDSpire?

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

Learn More

Choose specialties Cardiology Dermatology Endocrinology Family Medicine Gastroenterology Hematology Internal Medicine Neurology ObGyn Oncology Ophthalmology Optometry Pediatrics Rheumatology Pulmonary Psychiatry Pathology Surgery Orthopedic Medicine Radiology Otolaryngology Infectious Disease

Kff Health News

June 4, 2026

HHS Seeks Broader Access to Health Data

Amanda Seitz
Darius Tahir
June 4, 2026
12 min

Summary
Insight Report
Quiz
Poll
Top Thought Leaders

Objective: To pursue federal government access to Americans' medical records for research on vaccines and autism, a connection that the medical establishment ha

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

June 4, 2026

Could Isotretinoin Shorten Adult Height?

Kathryn Wighton
June 4, 2026
6 min

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard
Top Thought Leaders

Objective: To assess whether adolescent isotretinoin treatment for acne is associated with reductions in adult height, specifically focusing on treatment during

A nationwide Danish study found no significant reduction in adult height associated with adolescent isotretinoin treatment for acne.
The study analyzed data from 379,196 individuals who underwent military conscription examinations between 2001 and 2015.
Isotretinoin users showed adjusted mean height differences of only 0.3 cm compared to non-users, below the clinically relevant threshold of 5 cm.
Cumulative isotretinoin exposure did not demonstrate a dose-response relationship with adult height, indicating no growth impairment.
The findings may reassure clinicians and patients about isotretinoin's safety regarding height, despite some limitations in the study.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

June 4, 2026

WHtR May Aid OSA Risk Screening

Andrea Surnit
June 4, 2026
4 min

Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard
Top Thought Leaders

Higher waist-to-height ratio (WHtR) is linked to increased odds of obstructive sleep apnea (OSA) in diverse populations.
In NHANES, each 0.1-unit increase in WHtR correlated with approximately 2.8 times the odds of OSA.
In a clinical cohort, WHtR demonstrated stronger discrimination for OSA than body mass index (BMI), with an area under the curve of 0.88.
A WHtR cutoff of 0.501 showed 93% sensitivity and 81% specificity for identifying OSA in the clinical cohort.
The findings suggest WHtR may aid OSA risk screening, but further validation is needed before broader clinical application.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

The Pathologist

June 4, 2026

ASCO 2026: AI Challenges a Breast Cancer Standard

Jessica Allerton
June 4, 2026
3 min

Summary
Takeaways
Quiz
Clinical Scorecard
Top Thought Leaders

Objective: To compare the prognostic performance of a multimodal artificial intelligence histopathology-based tool (Artera) versus the 21-gene recurrence score

The Artera breast model is an FDA-cleared AI tool that integrates digital pathology and clinical variables for breast cancer risk stratification.
In a study of over 300 early-stage breast cancer patients, the Artera AI tool outperformed the 21-gene recurrence score in prognostic value.
Patients with concordantly low scores from both Artera and Oncotype had no distant recurrences at 10 years, indicating strong prognostic accuracy.
Discordant scores showed a significant difference in 10-year distant metastasis rates, with 20% recurrence in patients with Oncotype low and Artera high.
The study suggests that the Artera AI tool provides additional prognostic information beyond traditional recurrence score categories.

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

The Pathologist

June 4, 2026

Beating Tissue Failure in Oncology

Helen Bristow
June 4, 2026
8 min

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard
Top Thought Leaders

Objective: Revise to directly reference the challenges in oncology as mentioned in the source. Key Findings: Add source attribution for each finding. Interpreta

Imagenomix aims to enhance access to precision medicine using an AI-powered platform that analyzes standard H&E slides for molecular signals.
In the US, 25% of oncology cases exhaust biopsy tissue before molecular characterization, leading to missed opportunities for mutation testing.
AI prescreening can significantly reduce costs and time to treatment by identifying high-probability mutations before expensive confirmatory tests.
The Imagenomix platform can improve clinical trial efficiency by screening candidates and preserving tissue for molecular testing.
Preliminary studies indicate that Imagenomix's assays for lung and breast cancer mutations are on track for launch in late 2026.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

June 4, 2026

Side Effects: The Body Keeps Score

Kerri Miller
June 4, 2026
5 min

Summary
Insight Report
Poll
Clinical Scorecard
Top Thought Leaders
Topic Commentary

Objective: To explore the long-term effects of bariatric surgery on household management and the detection of sleep deprivation through saliva analysis. Key Fin

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top thought leaders in a clinical topic, with data-driven rankings and expert profiles highlighting their influence and contributions.

Explore Experts

Get expert commentary that brings together trusted external perspectives to add deeper context and insight around a clinical topic.

Explore Commentary

The Analytical Scientist

June 4, 2026

How Faults Lower Their Own Friction

June 4, 2026
2 min

Summary
Insight Report
Quiz
Poll

Objective: To investigate the role of naturally occurring graphene oxide in reducing friction along the Atotsugawa Fault System. Key Findings: Graphene oxide wa

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

The Ophthalmologist

June 4, 2026

Combination Therapy Targets Bacterial Keratitis

June 4, 2026
3 min

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard
Topic Commentary

Objective: To evaluate the efficacy of a combination of levofloxacin and ibuprofen in treating bacterial keratitis. Key Findings: Combination therapy outperform

A combination of levofloxacin and ibuprofen may enhance treatment for bacterial keratitis amid rising antimicrobial resistance.
In a rat model, combination therapy outperformed monotherapy in microbiological, molecular, and histological assessments.
Ibuprofen reduced the minimum inhibitory concentration of levofloxacin, indicating enhanced antibacterial potency.
Combination therapy resulted in lower inflammatory cytokine expression and improved corneal architecture compared to monotherapy.
The study's findings are exploratory, limited by small sample size and focus on Staphylococcus aureus, necessitating further research.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Get expert commentary that brings together trusted external perspectives to add deeper context and insight around a clinical topic.

Explore Commentary

The Ophthalmologist

June 4, 2026

New UK Framework for Glaucoma Care

June 4, 2026
2 min

Summary
Takeaways
Insight Report
Quiz
Poll

Objective: To reduce avoidable sight loss from glaucoma through improved early diagnosis, referral accuracy, and long-term patient follow-up. [Source needed] Ke

The Royal College of Ophthalmologists supports new NHS England guidance to reduce avoidable sight loss from glaucoma.
The Best Practice for Glaucoma Services framework aims to standardize glaucoma pathways and improve early diagnosis and referral accuracy.
The guidance promotes digitally enabled care pathways and increased service delivery in community settings for suspected glaucoma patients.
The framework advocates for high-volume virtual glaucoma clinics to enhance ongoing monitoring and reduce delays in follow-up appointments.
GIRFT will host a webinar to outline recommendations and explore collaboration among clinicians to improve glaucoma patient outcomes.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

The Ophthalmologist

June 4, 2026

Dual Therapy for Myopia Control

June 4, 2026
4 min

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard
Topic Commentary

Objective: To evaluate the effectiveness of combining low-dose atropine with Defocus Incorporated Multiple Segments (DIMS) spectacle lenses for myopia control i

The ASPECT trial indicates that combining low-dose atropine with DIMS lenses enhances myopia control compared to atropine alone.
At 12 months, axial elongation was significantly lower in the combination therapy group (0.07 mm) compared to the atropine-only group (0.18 mm).
Nearly 40% of children receiving combination therapy showed no axial elongation, compared to 12% in the control group.
The study suggests that achieving near-physiological axial growth could reduce the lifetime risk of myopia-related complications.
Tolerability of the combination therapy was good, although adherence to the regimen remains a challenge for patients.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Get expert commentary that brings together trusted external perspectives to add deeper context and insight around a clinical topic.

Explore Commentary

The Medicine Maker

June 4, 2026

Roving Reporter Asks: How Is Shifting Investment Reshaping Advanced Therapies?

June 4, 2026
1 min

Summary
Takeaways
Insight Report
Poll
Clinical Scorecard

Objective: To explore how changing investment patterns are influencing the advanced therapies sector. Key Findings: Tighter capital is leading to greater discip

Shifting investment patterns are significantly reshaping the advanced therapies sector.
The discussion emphasizes the importance of robust science and scalable manufacturing in advanced therapies.
Tighter capital is driving greater discipline and cost control within the advanced therapies field.
Strategic partnerships are becoming increasingly vital for companies in the advanced therapies sector.
Technologies must demonstrate clear real-world value to succeed in the evolving landscape of advanced therapies.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Digital Health

June 4, 2026

Computational modelling for personalized transcatheter aortic valve replacement planning: a systematic review of complications and decision support

Elisa Rauseo
Laura Bevis
Xu Chen
Steffen E. Petersen
Anthony Mathur
Gregory G. Slabaugh
Caroline H. Roney
June 4, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To evaluate modeling approaches addressing TAVR complications and procedural planning, particularly for high-risk scenarios, through a systematic rev

Patient-specific digital simulation supports personalized planning for transcatheter aortic valve replacement (TAVR) in younger, lower-risk patients.
Complications such as paravalvular leak, conduction disturbances, and coronary obstruction significantly impact TAVR outcomes.
Current pre-procedural planning primarily relies on computed tomography, which does not fully capture dynamic device-tissue interactions.
Computational modeling enhances TAVR planning by simulating valve deployment and device-tissue interactions to inform decision-making.
Despite advancements, clinical translation of computational models is limited by methodological variability and lack of integration into workflows.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Immunology

June 4, 2026

Neuroimmune cross-talk in Leptospira-associated acute encephalopathy syndrome

Khushboo Sharma
Neha Tiwari
Nalini Mishra
Manish Sharma
June 4, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To understand the immune-mediated mechanisms involved in Leptospira-associated acute encephalopathy syndrome (AES) and its implications for diagnosis

Leptospira-associated acute encephalopathy syndrome (AES) is primarily caused by immune-mediated mechanisms rather than direct infection of neuronal tissue.
The disease is characterized by dysregulation of glial responses and peripheral immunity, leading to blood-brain barrier disruption and neuronal dysfunction.
Enhanced circulating cytokines and endothelial dysfunction contribute to exacerbated cerebral edema, a hallmark of Leptospira-induced AES.
Leptospirosis is a neglected zoonotic disease, with significant morbidity and mortality, particularly in tropical and subtropical regions.
Improving diagnostic tools and awareness among healthcare providers is crucial for recognizing and managing leptospirosis and its neurological complications.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Medicine

June 4, 2026

Acupuncture as a potential host-directed therapeutic strategy in neuroinfectious diseases: a neuroimmune mechanistic perspective

Yun Jin Kim
June 4, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To examine the potential of acupuncture as a host-directed therapy (HDT) for neuroinfectious diseases by exploring its effects on neuroimmune mechani

Neuroinfectious diseases pose significant global health challenges, leading to high morbidity and mortality despite antimicrobial advancements.
Host-mediated immune responses play a crucial role in neurological outcomes, prompting interest in host-directed therapies (HDTs) to modulate these responses.
Acupuncture has emerged as a potential non-pharmacological HDT, showing promise in modulating inflammatory signaling and neuroimmune functions.
Current evidence for acupuncture's efficacy in neuroinfectious diseases is limited, primarily derived from non-infectious models requiring cautious interpretation.
Further systematic investigation is warranted to explore acupuncture's therapeutic potential in neuroinfectious diseases, given its plausible neuroimmune regulatory effects.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Neurology

June 4, 2026

Brain cortex activity of patients with disorders of consciousness under familiar and unfamiliar voice of subject's own name: an fNIRS-based study

Jinqin Zhang
Zhihong Jiao
Fubiao Huang
Xinping Wang
Xindiao Zhou
Qing Li
Ying Zhang
Liping Long
Yinuo Su
Kexin Cao
Yiheng Han
June 4, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard
Topic Commentary

Objective: To investigate the real-time cortical activation elicited by auditory sensory stimulation through familiar voice of subject's own name (FV SON) vs. u

This study utilized fNIRS to assess cortical activation in patients with disorders of consciousness (DOC) in response to familiar and unfamiliar voices.
Participants with DOC showed distinct cortical activation patterns when stimulated by familiar versus unfamiliar voices calling their name.
Under unfamiliar voice stimulation, participants exhibited deactivation in the Left Dorsolateral Pre-frontal Cortex (DLPFC-L).
Cortical responses to familiar voice stimulation were positively correlated with the Coma Recovery Scale-Revised (CRS-R) scores.
The findings suggest that auditory stimulation strategies may need to be personalized for effective rehabilitation in DOC patients.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Get expert commentary that brings together trusted external perspectives to add deeper context and insight around a clinical topic.

Explore Commentary

Frontiers In Neurology

June 4, 2026

Efficacy and safety of acupuncture for post-stroke spasticity: a study protocol for a randomized controlled trial

Zhihao Xiong
Juwei Dong
Yingying Zhu
Jiaxu Liu
Yini Hua
Yue Song
Jinxia Ni
Liangxiao Ma
Jing Bai
June 4, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To evaluate the efficacy, feasibility, and safety of acupuncture for post-stroke spasticity (PSS) and to explore the underlying anti-spasticity mecha

Post-stroke spasticity (PSS) is a significant complication affecting stroke recovery, leading to high morbidity and disability rates.
This study will evaluate the efficacy, feasibility, and safety of acupuncture for treating PSS in a randomized controlled trial.
A total of 180 patients will be randomly assigned to acupuncture, sham acupuncture, or basic treatment groups for a 4-week intervention.
Primary outcomes will include spasticity severity measured by the Modified Ashworth Scale, with secondary outcomes assessing motor function and daily activities.
The trial aims to clarify acupuncture's effectiveness for PSS and explore its underlying anti-spastic mechanisms.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Pediatrics

June 4, 2026

Editorial: Pediatric gastroenterology and visualizing the digestive tract

Samuel Bitton
Kenneth Ng
Muhammad A. Khan
June 4, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To discuss the technological advancements in pediatric gastroenterology and their significant impact on improving the diagnosis and treatment of gast

Pediatric gastroenterology is evolving with less invasive, more precise, and data-driven approaches for diagnosing and treating gastrointestinal disorders.
Minimally invasive endoscopy techniques like video capsule endoscopy and transnasal endoscopy enhance patient tolerability and broaden access to care.
Advancements in diagnostic precision, including confocal laser endomicroscopy and functional luminal imaging, improve disease characterization in children.
Therapeutic endoscopy techniques, such as endoscopic ultrasound and ERCP, are increasingly adapted for pediatric use, reducing the need for surgery.
The integration of artificial intelligence in pediatric endoscopy enhances lesion detection and standardizes reporting, promising improved clinical decision-making.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Immunology

June 4, 2026

Identification, design, and in vivo proof of concept of a shared APC neoantigen delivered via a self-amplifying RNA containing virus-like nanoparticle for cancer vaccination

Alfred J. Simmons
Anna S. Nikonova
Chloe D. Jonas
Katherine A. Pniewski
Deepak Upreti
Maria I. Perez
Satish Adhikari
June 4, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To develop and validate a novel cancer vaccine targeting APC-associated colorectal cancer (CRC) using a self-amplifying RNA virus-like nanoparticle.

Colorectal cancer (CRC) is a leading cause of cancer-related deaths, with over 80% of cases linked to mutations in the APC gene.
Familial Adenomatous Polyposis (FAP) is a hereditary disorder caused by APC gene mutations, leading to nearly 100% risk of developing CRC.
The study developed a virus-like nanoparticle to deliver a self-amplifying RNA replicon encoding neoantigens from the APC gene.
In vitro tests showed T-cell activation against the neoantigen, indicating potential for a robust immune response in vivo.
The findings support the use of APC-targeted vaccines as a promising strategy for preventing FAP-associated colorectal cancer.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Advertisement

Advertisement

Advertisement

About
Privacy Policy

Follow Us

Author/Creator Name

[Credentials]

[Current title or role]

Affiliations: [Institution, organization]

Specialties: Oncology Hematology

View Full Profile

Contributions:

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

Show all